HLS Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	55.74	55.5	56.62	63.07	61.47	60.01
Revenue Growth (YoY)	-1.81%	-1.98%	-10.23%	2.61%	2.43%	6.95%
Cost of Revenue	10.37	10.08	9	7.62	4.98	3.97
Gross Profit	45.38	45.42	47.62	55.45	56.49	56.04
Selling, General & Admin	27.51	27.71	32.59	33.86	35.58	32.06
Depreciation & Amortization Expenses	21.99	21.82	22.72	31.94	34.4	30.26
Other Operating Expenses	1.17	1.38	-2.4	6.22	5.19	0.17
Total Operating Expenses	50.67	50.9	52.91	72.02	75.17	62.49
Operating Income	-5.3	-5.48	-5.29	-16.57	-18.68	-6.45
Interest Expense	-5.41	-7.39	-10.29	-11.24	-5.04	-5.36
Total Non-Operating Income (Expense)	-5.41	-7.39	-10.29	-11.24	-5.04	-5.36
Pretax Income	-10.71	-12.88	-15.58	-27.8	-23.72	-11.81
Provision for Income Taxes	-0.42	-0.45	4.07	-0.27	-0.12	1.31
Net Income	-10.29	-12.43	-19.66	-27.53	-23.6	-13.12
Net Income to Common	-10.29	-12.43	-19.66	-27.53	-23.6	-13.12
Shares Outstanding (Basic)	31	32	32	32	32	32
Shares Outstanding (Diluted)	31	32	32	32	32	32
Shares Change (YoY)	-1.27%	-0.98%	-1.31%	-0.52%	0.77%	1.48%
EPS (Basic)	-0.32	-0.39	-0.62	-0.85	-0.73	-0.41
EPS (Diluted)	-0.32	-0.39	-0.62	-0.85	-0.73	-0.41
Shares Outstanding	31.27	31.27	31.79	31.98	32.36	32.45
Free Cash Flow	19.77	16.93	7.99	15.75	16.9	16.38
Free Cash Flow Growth	16.81%	111.88%	-49.28%	-6.80%	3.14%	76.00%
Free Cash Flow Per Share	0.63	0.54	0.25	0.49	0.52	0.51
Dividends Per Share	-	-	-	0.076	0.148	0.158
Dividend Growth	-	-	-	-48.76%	-6.50%	0.69%
Gross Margin	81.40%	81.83%	84.11%	87.91%	91.90%	93.38%
Operating Margin	-9.51%	-9.88%	-9.34%	-26.26%	-30.39%	-10.75%
Profit Margin	-18.46%	-22.40%	-34.71%	-43.65%	-38.39%	-21.86%
FCF Margin	35.47%	30.50%	14.11%	24.97%	27.49%	27.30%
EBITDA	16.69	16.33	17.43	15.37	15.72	23.81
EBITDA Margin	29.95%	29.43%	30.78%	24.37%	25.57%	39.68%
EBIT	-5.3	-5.48	-5.29	-16.57	-18.68	-6.45
EBIT Margin	-9.51%	-9.88%	-9.34%	-26.26%	-30.39%	-10.75%
Effective Tax Rate	3.92%	3.46%	-26.14%	0.98%	0.52%	-11.09%

Updated May 15, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.